je.st
news
Roche sees strong growth from breast cancer drugs
2015-10-22 13:02:38| Biotech - Topix.net
Roche Holding AG expects strong growth from its recent breast cancer drugs Perjeta and Kadcyla well into 2017, the company's head of pharmaceuticals said. Perjeta and Kadcyla increased sales by 66% and 57% respectively in the first nine months of 2015, Roche said Thursday as the Basel company announced a 2% increase in sales during the period.
Tags: strong
growth
cancer
drugs
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|